Search Results - "Ross, C J"

Refine Results
  1. 1
  2. 2

    Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children by Pussegoda, K, Ross, C J, Visscher, H, Yazdanpanah, M, Brooks, B, Rassekh, S R, Zada, Y F, Dubé, M-P, Carleton, B C, Hayden, M R

    Published in Clinical pharmacology and therapeutics (01-08-2013)
    “…Cisplatin is a widely used chemotherapeutic agent for the treatment of solid tumors. A serious complication of cisplatin treatment is permanent hearing loss…”
    Get full text
    Journal Article
  3. 3

    HLA-A31:01 and HLA-B15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children by Amstutz, U, Ross, C J D, Castro-Pastrana, L I, Rieder, M J, Shear, N H, Hayden, M R, Carleton, B C

    Published in Clinical pharmacology and therapeutics (01-07-2013)
    “…The occurrence of hypersensitivity reactions including rare but life‐threatening Stevens–Johnson syndrome (SJS) and drug‐induced hypersensitivity syndrome…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications by Oberlander, T F, Bonaguro, R J, Misri, S, Papsdorf, M, Ross, C J D, Simpson, E M

    Published in Molecular psychiatry (01-01-2008)
    “…Reduced Apgar scores and birth weight, increased risk of respiratory distress, jitteriness and increased tone have been reported in up to 30% of neonates with…”
    Get full text
    Journal Article
  6. 6

    Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system by Bodley-Tickell, A T, Olowokure, B, Bhaduri, S, White, D J, Ward, D, Ross, J D C, Smith, G, Duggal, H V, Goold, P

    Published in Sexually transmitted infections (01-08-2008)
    “…This study examines the distribution of selected sexually transmitted infections (STIs) in older people (aged >/=45 years) attending genitourinary medicine…”
    Get more information
    Journal Article
  7. 7

    Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent by Aminkeng, F, Ross, C J D, Rassekh, S R, Brunham, L R, Sistonen, J, Dube, M-P, Ibrahim, M, Nyambo, T B, Omar, S A, Froment, A, Bodo, J-M, Tishkoff, S, Carleton, B C, Hayden, M R

    Published in The pharmacogenomics journal (01-04-2014)
    “…There is established clinical evidence for differences in drug response, cure rates and survival outcomes between different ethnic populations, but the causes…”
    Get full text
    Journal Article
  8. 8

    Pulmonary Vascular Morphology as an Imaging Biomarker in Chronic Thromboembolic Pulmonary Hypertension by Rahaghi, F. N., Ross, J. C., Agarwal, M., González, G., Come, C. E., Diaz, A. A., Vegas-Sánchez-Ferrero, G., Hunsaker, A., Estépar, R. San José, Waxman, A. B., Washko, G. R.

    Published in Pulmonary circulation (01-03-2016)
    “…Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have morphologic changes to the pulmonary vasculature. These include pruning of the distal…”
    Get full text
    Journal Article
  9. 9

    The global spectrum of protein-coding pharmacogenomic diversity by Wright, G E B, Carleton, B, Hayden, M R, Ross, C J D

    Published in The pharmacogenomics journal (01-01-2018)
    “…Differences in response to medications have a strong genetic component. By leveraging publically available data, the spectrum of such genomic variation can be…”
    Get full text
    Journal Article
  10. 10

    Application of principal component analysis to pharmacogenomic studies in Canada by Visscher, H, Ross, C J D, Dubé, M-P, Brown, A M K, Phillips, M S, Carleton, B C, Hayden, M R

    Published in The pharmacogenomics journal (01-12-2009)
    “…Ethnicity can confound results in pharmacogenomic studies. Allele frequencies of loci that influence drug metabolism can vary substantially between different…”
    Get full text
    Journal Article
  11. 11

    Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels by Vaessen, S.F.C., Dallinga-Thie, G.M., Ross, C.J.D., Splint, L.J., Castellani, L.W., Rensen, P.C.N., Hayden, M.R., Schaap, F.G., Kuivenhoven, J.A.

    Published in Journal of lipid research (01-05-2009)
    “…Apolipoprotein AV (apoAV) overexpression causes a decrease in plasma triglyceride (TG) levels, while deficiency of apoAV causes hypertriglyceridemia in both…”
    Get full text
    Journal Article
  12. 12

    Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study by Madadi, P, Ross, CJD, Hayden, MR, Carleton, BC, Gaedigk, A, Leeder, JS, Koren, G

    Published in Clinical pharmacology and therapeutics (01-01-2009)
    “…A large number of women receive codeine for obstetric pain while breastfeeding. Following a case of fatal opioid poisoning in a breastfed neonate whose codeine…”
    Get full text
    Journal Article
  13. 13

    The influence of the noradrenergic/stress system on perceptual biases for reward by Ehlers, M. R., Ross, C. J. D., Todd, R. M.

    “…Previous research has established a role for the norepinephrine (NE)/stress system in individual differences in biases to attend to reward or punishment…”
    Get full text
    Journal Article
  14. 14

    Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children by Visscher, H., Ross, C.J.D., Rassekh, S.R., Sandor, G.S.S., Caron, H.N., van Dalen, E.C., Kremer, L.C., van der Pal, H.J., Rogers, P.C., Rieder, M.J., Carleton, B.C., Hayden, M.R.

    Published in Pediatric blood & cancer (01-08-2013)
    “…Background . The use of anthracyclines as effective antineoplastic drugs is limited by the occurrence of cardiotoxicity. Multiple genetic variants predictive…”
    Get full text
    Journal Article
  15. 15

    Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells by Ross, C J, Bastedo, L, Maier, S A, Sands, M S, Chang, P L

    Published in Human gene therapy (10-10-2000)
    “…Most lysosomal enzyme deficiencies are catastrophic illnesses with no generally available treatments. We have used the beta-glucuronidase-deficient mouse model…”
    Get more information
    Journal Article
  16. 16

    Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin by Brunham, L R, Lansberg, P J, Zhang, L, Miao, F, Carter, C, Hovingh, G K, Visscher, H, Jukema, J W, Stalenhoef, A F, Ross, C J D, Carleton, B C, Kastelein, J J P, Hayden, M R

    Published in The pharmacogenomics journal (01-06-2012)
    “…Statins reduce cardiovascular morbidity and mortality in appropriately selected patients. However, statin-associated myopathy is a significant risk associated…”
    Get full text
    Journal Article
  17. 17

    Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment by Ross, J D C, Jensen, J S

    Published in Sexually transmitted infections (01-08-2006)
    “…The evidence that Mycoplasma genitalium is a sexually transmitted pathogen is virtually incontrovertible based on both the concordance rates among partners and…”
    Get full text
    Journal Article Book Review
  18. 18

    Placental transport and fetal utilization of leucine in a model of fetal growth retardation by Ross, J.C. (University of Colorado School of Medicine, Denver, CO.), Fennessey, P.V, Wilkening, R.B, Battaglia, F.C, Meschia, G

    Published in The American journal of physiology (01-03-1996)
    “…Placental transport and fetal utilization of leucine were studied at 130 days of gestation in six control ewes and in seven ewes in which intrauterine growth…”
    Get full text
    Journal Article
  19. 19

    Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers by Sistonen, J, Madadi, P, Ross, C J, Yazdanpanah, M, Lee, J W, Landsmeer, M L A, Nauta, M, Carleton, B C, Koren, G, Hayden, M R

    Published in Clinical pharmacology and therapeutics (01-04-2012)
    “…Substantial variation exists in response to standard doses of codeine ranging from poor analgesia to life‐threatening central nervous system (CNS) depression…”
    Get full text
    Journal Article
  20. 20

    The emerging era of pharmacogenomics: current successes, future potential, and challenges by Lee, J.W., Aminkeng, F., Bhavsar, A.P., Shaw, K., Carleton, B.C., Hayden, M.R., Ross, C.J.D.

    Published in Clinical genetics (01-07-2014)
    “…The vast range of genetic diversity contributes to a wonderful array of human traits and characteristics. Unfortunately, a consequence of this genetic…”
    Get full text
    Journal Article